Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. - Wikidata - awgldk - TriplyDB

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.

http://www.wikidata.org/entity/Q37059428

about

Interferon-alpha for maintenance of follicular lymphoma Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.Follicular lymphoma: still Six characters in search of an author?Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma.Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.Transformation of follicular lymphoma The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma.Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma.Pathogenesis of follicular lymphoma Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma.Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy The microenvironment in mature B-cell malignancies: a target for new treatment strategies Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma.Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas.Biology and treatment of follicular lymphoma.Prognostic tools in follicular lymphomas.Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.Chemotherapy-free treatment in patients with follicular lymphoma.Role of tumor-associated macrophages in hematological malignancies.Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.JPEG2000 for automated quantification of immunohistochemically stained cell nuclei: a comparative study with standard JPEG format.Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma.Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells.Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.

P2860

Q24240781-9C60A6EB-D930-4849-8525-9283716A0F33 Q33488520-FF46A9BD-148B-4B04-8D7C-3DC98AC8DA00 Q33873518-22A8DD4D-9F1E-4DB1-93BC-394E46A8A394 Q33927978-A0070EE4-4FBA-4BEC-B106-0CFDF3977B1C Q33931720-864AD6C0-85EC-4073-A7B9-DFE33C5A0D1B Q34021592-792F092F-C05F-49C3-9D5D-DECE1E3534A8 Q34097414-E92C0A92-6819-420D-8A1F-B2D124FB3268 Q34532146-3159206D-50A8-4325-9D76-CCBA2CCCE2C9 Q35038729-0ACFE704-CDB4-458A-81CD-61EA90DBE74D Q35181974-2474D18F-93E0-4D78-B537-B85191EB3D03 Q35866406-D914F1BB-7B41-4F2A-AD5A-D1E5768E76DA Q36246716-E08121FE-C581-4170-9BF4-8BFFACE4E2AA Q36287398-C5DD2DE6-A1D7-428C-A0F1-EDA72F632D8C Q36290288-9FD7768C-2877-432F-B714-F9ECD2AB8B19 Q36715971-663D0DD0-1496-48E2-AB86-6D8471654305 Q37269044-20A1F737-C258-4693-90CA-A51169291CC1 Q37401508-F7341245-E165-43AF-BDE7-AECBEDCF5BE6 Q37427993-20CD22B3-8E55-464E-84E8-5A787C18AB81 Q37563816-8FF9ED85-589A-4A57-B7F2-BDDEFB044D24 Q37685586-181ACB84-2711-46BC-A853-31726086D6C3 Q37775633-C21114B8-57D3-40FB-AF1F-AAACD13FE1D7 Q37810118-AAF0A52B-7CF1-4123-AC11-B9F5E6FE69EC Q37810119-67FEBD6F-C801-4BE9-AE9B-80E250FEA58F Q37824996-0C248134-7222-4E26-B187-42FBC128E7BC Q38071077-FD71E202-B095-4FE0-8D0E-9ADA0FFB0FAE Q38317235-5E1D128B-C2CF-4994-84B0-29BDBAE5B119 Q38364405-E385559F-BE83-41D3-A29A-46A4411DD87B Q38506238-131115D7-75EA-48CC-BB5D-CCC6103E5EEB Q38572605-C1C1A3D9-A682-4874-B046-849A0A99C6B2 Q38577849-47088E21-D3D5-4DB6-8BBF-EA21F75FE80C Q39959220-AB05BA44-AD46-4122-AEFE-3AF69DB94062 Q39974868-CD2E1C52-A3D3-4EC1-A406-CAA302FF42EF Q40025028-AB0CEAD7-2FA9-44AF-B9E9-63408BA0724C Q40683450-77AC8DA7-BF24-4DB8-ACCD-38CEAE8C9B43 Q40922483-4E984DE9-F98E-429E-B3CF-A396F9305924 Q41085345-C37DCCC5-B68F-4803-B656-9D890EF61C3D Q42385116-FAD35987-64CA-4429-9A49-95C99AD3FDD1 Q43199543-31E7A6DF-517D-4177-BBFA-42315180DD8B Q43609842-32C42AFC-448E-499D-A2D5-D7F90A929C09 Q47131106-6B867CE9-C54B-435E-B090-C193EB003944

P2860

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.

http://www.wikidata.org/entity/Q37059428

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of the tumor microenvir ...... specific treatment protocols.

@en

Impact of the tumor microenvir ...... specific treatment protocols.

@nl

type

label

Impact of the tumor microenvir ...... specific treatment protocols.

@en

Impact of the tumor microenvir ...... specific treatment protocols.

@nl

prefLabel

Impact of the tumor microenvir ...... specific treatment protocols.

@en

Impact of the tumor microenvir ...... specific treatment protocols.

@nl

P1433

Q37059428-88EC19BD-C2BD-48FA-9E49-BE30F8474734

P1476

Q37059428-46FE4BE0-765B-4999-9DAB-E5A716C9FC53

P2093

Q37059428-1B84D1EC-6C3E-4F94-9B1A-09EB54B870CD

Q37059428-4E85DA18-9540-460E-BC26-191DE4A59DB1

Q37059428-63C0609D-7ED9-4BAD-8146-079EEF0B56E4

Q37059428-9E030E8D-225A-4CF9-A6D6-F27D5CAB5010

Q37059428-A4D2909E-38A9-4BBF-810C-CCAE8C5F321C

Q37059428-C3551AF2-7F68-4FCF-875A-3D3F04ABB626

Q37059428-CEC9F654-54F5-4531-A3D3-646B95C59252

Q37059428-FEB58AFB-9791-406F-8FF9-7BF3FF77721F

P2860

Q37059428-06CE3FF2-496E-4299-B2E8-241FFAA976A0

Q37059428-0D3DF785-B78A-46BC-A2BD-BCEA8B63014C

Q37059428-0F66EB13-EFBF-4070-A0B4-5167672860B0

Q37059428-165F1B95-971C-4C15-82A5-AA6042446BB6

Q37059428-1805AE70-A886-482F-9803-FCA235BA7FD2

Q37059428-23B9FFE2-84C7-4B56-B858-6DB56AF65784

Q37059428-24286ABA-DF15-4F49-B9DB-8A9F2CF34342

Q37059428-3956A267-9CF0-469F-9D19-FCB5069411D1

Q37059428-3C82E754-F662-4A07-955A-780FD63AB28E

Q37059428-50646661-D9C6-4BD2-B5DB-001C536A24F4

P304

Q37059428-CFD03F1E-37CA-4E2D-B73F-9C50E14CCEED

P31

Q37059428-23E4D9E8-5406-4E4D-AB98-35688C6780C9

P356

Q37059428-16707603-BAE1-4D06-ADEB-22D2C0FA0ECB

P433

Q37059428-2E24E0DD-35C3-45F8-809D-020B2E30CA81

P478

Q37059428-DA591F34-1DB5-4A1D-9FF8-25E763F2A3B8

P577

Q37059428-3A8FDC68-1AC5-4003-8491-BB17B1E2C4FC

P5875

Q37059428-6769B36F-4181-44B8-BDA4-CD527483E3BA

P698

Q37059428-62943F54-410C-49D5-B9E5-71DEBEA1BEF2

P932

Q37059428-82619358-8DD0-4E21-A38E-D540BC2C20A3

P356

P1433

P1476

Impact of the tumor microenvir ...... specific treatment protocols.

@en

P2093

Ad Koster

http://www.w3.org/2001/XMLSchema#string

Anton Hagenbeek

http://www.w3.org/2001/XMLSchema#string

Daphne de Jong

http://www.w3.org/2001/XMLSchema#string

Dennis Veldhuizen

http://www.w3.org/2001/XMLSchema#string

Jan Paul de Boer

http://www.w3.org/2001/XMLSchema#string

John Raemaekers

http://www.w3.org/2001/XMLSchema#string

Martine van Glabbeke

http://www.w3.org/2001/XMLSchema#string

Sabien Heisterkamp

http://www.w3.org/2001/XMLSchema#string

P2860

Follicular lymphoma: have we made any progress?

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Natural regulatory T cells and self-tolerance.

Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.

Lymphoma microenvironment: culprit or innocent?

Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.

P304

70-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.13574

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23627008

http://www.w3.org/2001/XMLSchema#string

P698

19059937

http://www.w3.org/2001/XMLSchema#string

P932

2625428

http://www.w3.org/2001/XMLSchema#string